Axsome Therapeutics Inc (AXSM)
72.50
-1.22
(-1.66%)
USD |
NASDAQ |
May 10, 16:00
72.00
-0.50
(-0.69%)
After-Hours: 19:30
Axsome Therapeutics 1 Year Total Returns (Daily): -3.93% for May 9, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 09, 2024 | -3.93% |
| May 08, 2024 | -2.64% |
| May 07, 2024 | 4.34% |
| May 06, 2024 | 2.98% |
| May 03, 2024 | 3.95% |
| May 02, 2024 | 4.08% |
| May 01, 2024 | 5.82% |
| April 30, 2024 | 3.12% |
| April 29, 2024 | 3.02% |
| April 26, 2024 | 2.28% |
| April 25, 2024 | 0.41% |
| April 24, 2024 | -2.93% |
| April 23, 2024 | 0.22% |
| April 22, 2024 | -2.50% |
| April 19, 2024 | -5.89% |
| April 18, 2024 | -9.79% |
| April 17, 2024 | -1.06% |
| April 16, 2024 | 0.45% |
| April 15, 2024 | -0.42% |
| April 12, 2024 | 8.66% |
| April 11, 2024 | 17.53% |
| April 10, 2024 | 15.23% |
| April 09, 2024 | 21.57% |
| April 08, 2024 | 20.69% |
| April 05, 2024 | 23.69% |
| Date | Value |
|---|---|
| April 04, 2024 | 20.42% |
| April 03, 2024 | 16.70% |
| April 02, 2024 | 20.88% |
| April 01, 2024 | 24.82% |
| March 28, 2024 | 29.74% |
| March 27, 2024 | 23.86% |
| March 26, 2024 | 23.82% |
| March 25, 2024 | 24.84% |
| March 22, 2024 | 28.11% |
| March 21, 2024 | 28.59% |
| March 20, 2024 | 24.76% |
| March 19, 2024 | 22.52% |
| March 18, 2024 | 15.62% |
| March 15, 2024 | 21.98% |
| March 14, 2024 | 10.05% |
| March 13, 2024 | 14.85% |
| March 12, 2024 | 18.84% |
| March 11, 2024 | 21.48% |
| March 08, 2024 | 16.30% |
| March 07, 2024 | 13.45% |
| March 06, 2024 | 8.79% |
| March 05, 2024 | 17.37% |
| March 04, 2024 | 19.79% |
| March 01, 2024 | 23.22% |
| February 29, 2024 | 19.34% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-74.78%
Minimum
Aug 19 2021
5.08K%
Maximum
Dec 26 2019
213.4%
Average
52.96%
Median
Mar 18 2021
1 Year Total Returns (Daily) Benchmarks
| Krystal Biotech Inc | 72.88% |
| Amgen Inc | 37.93% |
| Vertex Pharmaceuticals Inc | 21.51% |
| Alnylam Pharmaceuticals Inc | -27.17% |
| Catalyst Pharmaceuticals Inc | -10.00% |